Clarivate Plc(CLVT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.52 | Insider Own | 47.71% | Shs Outstand | 639.7M | Perf Week | -5.34% |
| Market Cap | 1.25B | Forward P/E | 2.55 | EPS next Y | 3.34% | Insider Trans | -0.52% | Shs Float | 334.5M | Perf Month | 2.09% |
| Enterprise Value | 5.29B | PEG | 0.33 | EPS next Q | 0.18 | Inst Own | 62.78% | Short Float | 15.26% | Perf Quarter | -14.1% |
| Income | -0.33B | P/S | 0.52 | EPS this Y | 7.39% | Inst Trans | 0.84% | Short Ratio | 7.8 | Perf Half Y | -26.97% |
| Sales | 2.41B | P/B | 0.27 | EPS next 5Y | 7.63% | ROA | -3.05% | Short Interest | 51.03M | Perf YTD | -41.62% |
| Book/sh | 7.09 | P/C | 5.73 | EPS past 3/5Y | 63.69% 16.31% | ROE | -7.01% | 52W High | -56.28% ($4.46) | Perf Year | -54.01% |
| Cash/sh | 0.34 | P/FCF | 3.81 | Sales past 3/5Y | -2.63% 14.38% | ROIC | -3.81% | 52W Low | 17.47% ($1.66) | Perf 3Y | -72.1% |
| Dividend Est. | - | EV/EBITDA | 5.67 | EPS Y/Y TTM | 16.13% | Gross Margin | 35.71% | Volatility(W/M) | 5.9% 6.07% | Perf 5Y | -91.79% |
| Dividend TTM | - | EV/Sales | 2.19 | Sales Y/Y TTM | -3.5% | Oper. Margin | 7.51% | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.85 | EPS Q/Q | -297.45% | Profit Margin | -13.84% | RSI (14) | 45.25 | Recom | 2.56 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.85 | Sales Q/Q | -5.49% | SMA20 | -3.27% ($2.02) | Beta | 1.39 | Target Price | $2.88 |
| Payout | - | Debt/Eq | 0.94 | Earnings | 2026/7/29 | SMA50 | -7.02% ($2.1) | Rel Volume | 0.77 | Prev Close | $1.91 |
| Employees | 12000 | LT Debt/Eq | 0.93 | EPS/Sales Surpr. | 4.63% -0.41% | SMA200 | -23.26% ($2.54) | Avg Volume(3M) | 6.54M | Price | $1.95 |
| IPO | 2018/10/29 | Option/Short | Yes/Yes | Trades | 12317 | Volume | 5,046,926 | Change | 2.09% |
Company
CLVT is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
📚 A global information services company that provides academic, intellectual property, and life sciences data and analytics services. It offers subscription-based access to academic research data, patent and trademark intellectual property information, and life sciences/healthcare data, and delivers solutions that combine data analytics with artificial intelligence capabilities. The company has established itself as a subscription-based information services provider specializing in professional data and analytics.
Over the past 1 year, on the lower side
56% below its 1-year high.
CLVT has weak earning power
7.51% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +7.4% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -72.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 62.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FXL 0.02%
FFLS 0.02%
BTR 0.02%
OPTZ 0.01%
FDLS 0.01%It ranks #4 in the industry
Based on market cap of $1B.
CLVT $1B PER -
IBM $220B PER 20.8
ACN $109B PER 14.2
INFY $44B PER 13.4
FAQ
What kind of company is CLVT?
CLVT belongs to the Technology sector and operates in the Information Technology Services industry.
What is the market cap of CLVT?
The market cap of CLVT is approximately $1.2B, ranking 2,467 within its sector.
What is the 52-week high and low for CLVT?
CLVT has recorded a 52-week high of $4.46 and a low of $1.66.
